ISSN: 2471-9846

Journal of Community & Public Health Nursing
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Monoclonal antibody and blood plasma abo blood group based therapy against covid-19

7th World Congress on Nursing Education & Research & 39th Global Nursing Care & Patient Safety

Shimuye Kalayu Yirga

Fujian Medical University, China

ScientificTracks Abstracts: J Comm Pub Health Nurs

Abstract
In new decade new coronavirus emerged. COVID-19 (SARS-CoV-2) has nucleic acid sequence similarity 96% with bat coronavirus, 79.6% SARS-CoV-1. SARS-CoV-2 and SARS-CoV-1 have common human host-cell ACE2 receptor. This similarity helps for effective vaccine and antibody development. At Wuhan, China, convalescent plasma therapy achieved 70% recovery results. ABO blood group susceptibility study revealed O blood group were very low risk whereas A were at high risk against COVID-19. ABO natural antibodies have positive effect to slowdown COVID-19 in less hygienic environment (less developed) regions. Isolation of specific antibody from EBV transformed B-lymphocyte recovered patients is encouraged. Production of potent neutralizing antibody and vaccine is required. We identified the sensitive immunogenic amino acid segment (318-510) in S1-protein domain that contains important and essential amino acids including cysteine, glutamic acid and aspartic acid, which associated with ACE2 expression. Keywords: Monoclonal antibody, COVID-19, Spiked protein, ACE2, ABO blood group
Biography

Shimuye Kalayu Yirga is an assistant professor from woldia university, Ethiopia. He did Ph.D. in the field of pharmacy. Currently, he is postdoctoral staff at Department of internal medicine (Hematology), Fujian Medical University Union Hospital, China.

Relevant Topics
Top